|Articles|August 26, 2020

Study Suggests Streamlining Fewer Infection-Control Measures to Reduce C Diff

Author(s)Jonna Lorenz

Hospitals considering interventions to reduce Clostridioides difficile infections may find that less is more, according to a new study that found daily cleaning with sporicidal products to be the most cost-effective single infection control strategy.

Daily cleaning with sporicidal products is the most cost-effective single infection control strategy to reduce Clostridioides difficile in hospitals, according to a new study.

The study, published in JAMA Network Open, evaluated 9 single intervention strategies and 8 intervention bundles at a simulated 200-bed hospital using a simulation model of C diff transmission.

“The findings of this study suggest that institutions should streamline infection control bundles, prioritizing a small number of highly cost-effective interventions,” the authors noted in the study, which was completed by investigators at the University of Michigan, the University of Wisconsin-Madison, and William S. Middleton Memorial Veterans Hospital.

Health care facilities are a major source of C diff infections (CDI), which cause more than 15,000 deaths and $5 billion in health care costs each year in the United States. An earlier study estimated that the incidence of C diff infection in the United States is approximately 8.3 cases per 10,000 patient-days, and that the excess hospital length of stay related to C diff infection ranged from 3 to 21 days.

The model simulated a hospital environment, evaluated the probability of transmission during a given interaction between patients, visitors, nurses and physicians, and simulated the effects of various interventions.

Daily cleaning was found to be most cost-effective single intervention, saving $358, 268, 36.8 quality-adjusted life-years (QALY) and 25.9 infections annually. Other strategies that resulted in cost savings, increased QALYs and averted infections included health care worker hand hygiene, patient hand hygiene, terminal cleaning, and reducing intrahospital patient transfers.

The study evaluated bundling 2, 3 or 4 interventions, including daily cleaning. While bundles with 2 interventions were found to be cost-effective, cost-effectiveness decreases as interventions are added. Adding screening for C diff colonization at admission, health care worker hand hygiene, and patient hand hygiene sequentially cost $29, 616 per QALY, $50, 196 per QALY, and $146 ,792 perQALY, respectively.

Visitor contact precautions were the found to be the least cost-effective, costing as much as $1,669,089 per QALY.

“Recognizing that all hospitals operate in an environment of constrained resources, support must be shifted from minimally effective, high-cost interventions, such as visitor contact precautions, to more innovative, cost-effective solutions,” the study noted.

A recent study found that more than half of infection-control bundles include 6 or more interventions.

“(O)ur results provide evidence that continuing to increase bundles without accounting for the cost and effectiveness of individual components may be counterproductive, depending on institutional priorities and cost constraints,” the study said. “Instead, institutions should consider streamlining their infection control initiatives and may opt to focus on a smaller number of highly cost-effective interventions.”

The study likely underestimates cost-effectiveness because the model did not stratify infections by severity or include complications, instead evaluating all cases as mild to moderate.

Efforts to control CDI have increased. Collaborations between antimicrobial stewards and infection preventionists have helped reduce hospital-onset CDI, and there has been a shift toward vertical infection-prevention methods. A recent study found that cases dropped by 24% between 2011 and 2017 as hospitals have focused on antibiotic stewardship programs.


Related to this article

Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.